Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on November 24, 2015, reporting the issuance of €425,000,000 in aggregate principal amount of 1.500% Senior Notes due 2020. This offering was conducted under a previously filed registration statement and prospectus. The company has applied to list these notes on the New York Stock Exchange (NYSE). The proceeds from this issuance are intended to be used for specific purposes, notably to redeem all outstanding $400 million of 3.50% senior notes due 2016 issued by its subsidiary, Life Technologies Corporation. Any remaining proceeds will be allocated to general corporate purposes. The notes are general unsecured obligations, subject to certain subordination and change of control provisions, and are governed by an indenture that includes limited affirmative and negative covenants.
Key Highlights
- 1Thermo Fisher Scientific Inc. issued €425 million of 1.500% Senior Notes due 2020.
- 2The offering was conducted via a public offering under a Form S-3 registration statement.
- 3The company intends to list the new notes on the New York Stock Exchange (NYSE).
- 4Proceeds will be used to redeem the outstanding $400 million of 3.50% senior notes due 2016 from subsidiary Life Technologies Corporation.
- 5The notes are general unsecured obligations and are effectively subordinated to secured indebtedness.
- 6A change of control event coupled with a downgrade to below investment grade by two rating agencies triggers a mandatory repurchase offer at 101% of principal.
- 7The indenture includes covenants restricting the incurrence of secured debt, sale-leaseback transactions, and significant asset sales.